These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9054633)

  • 1. N-nitrosation of medicinal drugs catalysed by bacteria from human saliva and gastro-intestinal tract, including Helicobacter pylori.
    Ziebarth D; Spiegelhalder B; Bartsch H
    Carcinogenesis; 1997 Feb; 18(2):383-9. PubMed ID: 9054633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation.
    Mowat C; Williams C; Gillen D; Hossack M; Gilmour D; Carswell A; Wirz A; Preston T; McColl KE
    Gastroenterology; 2000 Aug; 119(2):339-47. PubMed ID: 10930369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach.
    Pignatelli B; Malaveille C; Rogatko A; Hautefeuille A; Thuillier P; Muñoz N; Moulinier B; Berger F; De Montclos H; Lambert R
    Eur J Cancer; 1993; 29A(14):2031-9. PubMed ID: 8280498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach.
    Leach SA; Thompson M; Hill M
    Carcinogenesis; 1987 Dec; 8(12):1907-12. PubMed ID: 3119247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies indicate that acid catalysed generation of N-nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia.
    Moriya A; Grant J; Mowat C; Williams C; Carswell A; Preston T; Anderson S; Iijima K; McColl KE
    Scand J Gastroenterol; 2002 Mar; 37(3):253-61. PubMed ID: 11916186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology.
    Bartsch H; Ohshima H; Pignatelli B; Calmels S
    Pharmacogenetics; 1992 Dec; 2(6):272-7. PubMed ID: 1339085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori does not mediate the formation of carcinogenic N-nitrosamines.
    Vermeer IT; Gerrits MM; Moonen EJ; Engels LG; Dallinga JW; Kleinjans JC; van Maanen JM; Kuipers EJ; Kusters JG
    Helicobacter; 2002 Jun; 7(3):163-9. PubMed ID: 12047321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-nitroso compounds and human cancer: where do we stand?
    Bartsch H
    IARC Sci Publ; 1991; (105):1-10. PubMed ID: 1855828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalysis and inhibition of N-nitrosation reactions.
    Archer MC
    IARC Sci Publ; 1984; (57):263-74. PubMed ID: 6398294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method.
    Xu GP; Reed PI
    Carcinogenesis; 1993 Dec; 14(12):2547-51. PubMed ID: 8269625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of bacterially mediated N-nitrosation by vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach.
    Mackerness CW; Leach SA; Thompson MH; Hill MJ
    Carcinogenesis; 1989 Feb; 10(2):397-9. PubMed ID: 2492212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in gastric carcinogenesis. V. The effects of ascorbic acid on N-nitroso compound formation in human gastric juice in vivo and in vitro.
    Kyrtopoulos SA; Pignatelli B; Karkanias G; Golematis B; Esteve J
    Carcinogenesis; 1991 Aug; 12(8):1371-6. PubMed ID: 1860156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic semi-permeable polyethyleneimine microcapsules for monitoring of N-nitrosation in the gastrointestinal tract.
    O'Neill IK; Castegnaro M; Brouet I; Povey AC
    Carcinogenesis; 1987 Oct; 8(10):1469-74. PubMed ID: 3652383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia.
    Suzuki H; Iijima K; Moriya A; McElroy K; Scobie G; Fyfe V; McColl KE
    Gut; 2003 Aug; 52(8):1095-101. PubMed ID: 12865265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products.
    Brambilla G; Martelli A
    Mutat Res; 2007; 635(1):17-52. PubMed ID: 17157055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nitrosamine formation by ascorbic acid.
    Tannenbaum SR; Wishnok JS; Leaf CD
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):247S-250S. PubMed ID: 1985394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrosation of orally administered drugs under simulated stomach conditions.
    Ziebarth D; Teichmann B
    IARC Sci Publ; 1980; (31):231-44. PubMed ID: 7228255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial formation of N-nitroso compounds from administered precursors in the rat stomach after omeprazole-induced achlorhydria.
    Calmels S; Béréziat JC; Ohshima H; Bartsch H
    Carcinogenesis; 1991 Mar; 12(3):435-9. PubMed ID: 1901250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention.
    Bartsch H; Ohshima H; Pignatelli B
    Mutat Res; 1988 Dec; 202(2):307-24. PubMed ID: 3057363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrosation of drugs under in-vivo conditions.
    Walters CL; Gillatt PN; Palmer RC; Smith PL; Reed PI
    IARC Sci Publ; 1987; (84):351-4. PubMed ID: 3679400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.